The gastrointestinal endoscopy market has seen considerable growth due to a variety of factors.
•The market size for gastrointestinal endoscopy has been on a considerable rise in the past years. The market forecast asserts growth from $15.82 billion in 2024 to a whopping $16.85 billion in 2025, implying a compound annual growth rate (CAGR) of 6.5%.
The notable growth in the historic span is owing to several factors including the escalating incidence of gastrointestinal ailments, enhanced consciousness about early detection of diseases, the growth in the elderly population, favorable reimbursement policies, and broadening applications in therapy procedures.
The gastrointestinal endoscopy market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for gastrointestinal endoscopy is predicted to experience substantial growth in the upcoming years. The market is forecasted to reach $22.11 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.0%.
Factors contributing to this growth during the forecast period include an increase in the demand for minimally invasive procedures, investment in healthcare infrastructure, the expansion of the elderly population, broader applications in cancer diagnosis, and the popularization of capsule endoscopy. Other emerging trends during this period will be the integration of artificial intelligence in endoscopy, the creation of disposable endoscopes, a surge in the demand for flexible endoscopes, an emphasis on tele-endoscopy services, and the incorporation of robotics in gastrointestinal endoscopy.
The rising incidence of gastrointestinal disorders is propelling progress in the gastrointestinal endoscopy market. These disorders collectively impact the gastrointestinal (GI) tract, which encompasses the organs that aid in digestion and metabolizing food. Gastrointestinal endoscopy, a popular method to diagnose and treat these conditions, helps in spotting irregularities, obtaining tissue samples for biopsy, and carrying out therapeutic procedures. For instance, Cancer Research UK, a standalone cancer research organization based in the UK, anticipates a 5% surge in pancreatic cancer cases in the UK from 2023 to 2025. Moreover, a study published in the Journal of the Canadian Association of Gastroenterology, a Canadian refereed open-access journal, in March 2023 predicts that the rate of inflammatory bowel disease in Canada will rise from 825 per 100,000 in 2023 to 1075 per 100,000 in 2035. Thus, the escalating occurrence of gastrointestinal disorders is driving the growth of the gastrointestinal endoscopy market.
The gastrointestinal endoscopy market covered in this report is segmented –
1) By Product: Endoscopes, Camera Heads, Visualization Systems, Biopsy Devices, Capsule Endoscopes, Transmitters And Receivers, Robot-Assisted Endoscopes
2) By Application: OGIB (Obscure GI Tract Bleeding), Crohn’s Disease, Small Intestine Tumor, Other Applications
3) By End User: Hospitals, Ambulatory Surgery Centers Or Clinics, Other End Users
Subsegments:
1) By Endoscopes: Rigid Endoscopes, Flexible Endoscopes, Single-Use Endoscopes
2) By Camera Heads: Standard Camera Heads, High-Definition Camera Heads, 3D Camera Heads
3) By Visualization Systems: Integrated Visualization Systems, Monitors And Display Systems
4) By Biopsy Devices: Biopsy Forceps, Needle Biopsy Devices, Endoscopic Mucosal Resection Devices
5) By Capsule Endoscopes: Small Bowel Capsule Endoscopes, Colon Capsule Endoscopes
6) By Transmitters And Receivers: Wireless Transmitters, Signal Receivers
7) By Robot-Assisted Endoscopes: Robotic Endoscope Systems, Accessories For Robotic Endoscopy
Leading enterprises in the gastrointestinal endoscopy market are revolutionising the sector by launching cutting-edge endoscopic devices. These devices incorporate state-of-the-art imaging technologies to boost diagnostic precision and optimise patient results. Such imaging solutions include high-definition imaging, narrow-band imaging (NBI), and optical coherence tomography (OCT), which all provide a more comprehensive and defined perspective of the gastrointestinal tract through endoscopic procedures. For example, a manufacturing company based in Japan, Olympus Corporation, announced the EVIS X1 Endoscopy System in October 2023. This innovative, next-generation equipment is constructed to amplify the visualisation of the gastrointestinal tract using pioneering imaging technologies like TXI, RDI, and NBI. Its purpose is to refine the identification of irregularities during GI procedures, giving doctors superior diagnostic abilities.
Major companies operating in the gastrointestinal endoscopy market include:
• Medtronic plc
• Johnson & Johnson MedTech
• FUJIFILM Holdings Corporation
• Stryker Corporation
• Boston Scientific Corporation
• Envaste Limited
• Olympus Corporation
• Intuitive Surgical Inc.
• HOYA Corporation
• Smith & Nephew Plc
• Steris plc
• Coloplast AS
• Teleflex Incorporated
• Cook Group Inc.
• Karl Storz SE & Co. KG
• Ambu A/S
• Richard Wolf GmbH
• SonoScape Medical Corp.
• EndoChoice Holdings Inc.
• Allied Digestive Health LLC
• Endogastric Solutions Inc.
• Micro-Tech Endoscopy Inc.
• CapsoVision Inc.
• Medrobotics Corporation
• EndoMed Systems GmbH
• Motus GI Holdings Inc.
• Endogene Ltd.
North America was the largest region in the gastrointestinal endoscopy market in 2024. The regions covered in the gastrointestinal endoscopy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa